DE69326173D1 - Schwefel enthaltende bizyklische Verbindungen zur Behandlung von durch Immunsystemstörungen verursachte Krankheiten - Google Patents

Schwefel enthaltende bizyklische Verbindungen zur Behandlung von durch Immunsystemstörungen verursachte Krankheiten

Info

Publication number
DE69326173D1
DE69326173D1 DE69326173T DE69326173T DE69326173D1 DE 69326173 D1 DE69326173 D1 DE 69326173D1 DE 69326173 T DE69326173 T DE 69326173T DE 69326173 T DE69326173 T DE 69326173T DE 69326173 D1 DE69326173 D1 DE 69326173D1
Authority
DE
Germany
Prior art keywords
treatment
immune system
compounds containing
diseases caused
containing sulfur
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69326173T
Other languages
English (en)
Other versions
DE69326173T2 (de
Inventor
Shiro Mita
Yoichi Kawashima
Ken-Ichi Fujimura
Hiroshi Suhara
Masahiro Okamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of DE69326173D1 publication Critical patent/DE69326173D1/de
Application granted granted Critical
Publication of DE69326173T2 publication Critical patent/DE69326173T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
DE69326173T 1992-01-31 1993-01-25 Schwefel enthaltende bizyklische Verbindungen zur Behandlung von durch Immunsystemstörungen verursachte Krankheiten Expired - Fee Related DE69326173T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4060887A JP2906236B2 (ja) 1992-01-31 1992-01-31 ビシクロ化合物

Publications (2)

Publication Number Publication Date
DE69326173D1 true DE69326173D1 (de) 1999-10-07
DE69326173T2 DE69326173T2 (de) 2000-03-09

Family

ID=13155329

Family Applications (2)

Application Number Title Priority Date Filing Date
DE93300520T Pending DE554032T1 (de) 1992-01-31 1993-01-25 Schwefel enthaltende bizyklische Verbindungen zur Behandlung von durch Immunsystemstörungen verursachte Krankheiten.
DE69326173T Expired - Fee Related DE69326173T2 (de) 1992-01-31 1993-01-25 Schwefel enthaltende bizyklische Verbindungen zur Behandlung von durch Immunsystemstörungen verursachte Krankheiten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE93300520T Pending DE554032T1 (de) 1992-01-31 1993-01-25 Schwefel enthaltende bizyklische Verbindungen zur Behandlung von durch Immunsystemstörungen verursachte Krankheiten.

Country Status (6)

Country Link
US (1) US5350860A (de)
EP (1) EP0554032B1 (de)
JP (1) JP2906236B2 (de)
DE (2) DE554032T1 (de)
ES (1) ES2049712T1 (de)
GR (1) GR940300002T1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69231892T2 (de) * 1991-01-10 2001-11-15 Santen Pharmaceutical Co Ltd Cyclische verbindung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6058973A (ja) * 1983-09-13 1985-04-05 Mitsubishi Yuka Yakuhin Kk γ−プチロラクトン誘導体及びそれを有効成分とする免疫調節剤
DE69231892T2 (de) * 1991-01-10 2001-11-15 Santen Pharmaceutical Co Ltd Cyclische verbindung

Also Published As

Publication number Publication date
EP0554032A2 (de) 1993-08-04
JPH05213961A (ja) 1993-08-24
DE554032T1 (de) 1994-02-24
JP2906236B2 (ja) 1999-06-14
EP0554032A3 (en) 1993-08-18
EP0554032B1 (de) 1999-09-01
DE69326173T2 (de) 2000-03-09
US5350860A (en) 1994-09-27
ES2049712T1 (es) 1994-05-01
GR940300002T1 (de) 1994-02-28

Similar Documents

Publication Publication Date Title
DE69307509T2 (de) Vorrichtung zur behandlung von herzfehlern
DE69315257D1 (de) Simethicon enthaltende Arzneimittel zur Behandlung gastrointestinaler Störungen
DE69319551T2 (de) Indolin Verbindungen zur Behandlung von Dysurien
DE69124293D1 (de) Vorrichtung zur Behandlung von Wirbelsäulenerkrankungen
DE69115920D1 (de) Verfahren zur Behandlung von schmelzgeblasenen Filamenten
DE69313872T2 (de) Verbindung von nucleocidanaloga zur behandlung viraler infektionen
DE59306642D1 (de) Verfahren zur Herstellung von Calcium-L-ascorbat-2-phosphat
DE69103214D1 (de) Verfahren zur Reinigung von Glycin.
DE69326173T2 (de) Schwefel enthaltende bizyklische Verbindungen zur Behandlung von durch Immunsystemstörungen verursachte Krankheiten
DE69329591D1 (de) Verfahren zur Herstellung wasserdispergierbarer Diclofenac enthaltender Tabletten
DE69314413T2 (de) Piperidino-3,4-dihydrocarbostyryl Verbindungen zur Behandlung von ischämischen Störungen
DE69327133D1 (de) Verfahren zur Dehydrierung von polyzyklischen Verbindungen
ATE135702T1 (de) Aryl- oder heteroaryl-1-alkyl-pyrrol-2- carbonsäure-derivate, zur behandlung von durch interleukin-1 hervorgerufenen erkrankungen
DE520834T1 (de) PP14 oder Antikörper gegen PP14 enthaltende pharmazeutische Zusammensetzung zur Behandlung von Immunsystemstörungen.
DE69320111D1 (de) Verfahren zur selektiven Ortho-Fluorierung substituierter aromatischer Verbindungen
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
DE69125969T2 (de) Arzneimittel zur Behandlung zentraler neuro-degenerativer Erkrankungen
DE68918449T2 (de) Siliziumverbindungen zur behandlung von knochen.
DE69205341D1 (de) Verfahren zur Reinigung von Diaminodiphenylverbindungen.
DE69314086T2 (de) Verfahren zur Reinigung von 4,4'-Diaminodiphenylmethan
DE69103294D1 (de) Verwendung der 3-Oxygermylpropionsäure zur Behandlung und Prävention von Diabetes verursacht durch Autoimmunkrankheiten.
DE69326367T2 (de) Verfahren und Verbindungen zur Herstellung von Carbacephemen
PT79047A (de) Azolyl-propannitrile verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
ATE57094T1 (de) Mittel zur behandlung von erkrankungen der zahnwurzelhaut.
PT77577B (de) 5-phenoxybenzoesaeurederivate von pentiten verfahren zur herstellung dieser verbindungen sowie diese enthaltende mittel mit herbizider wirkung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee